TESARO INC's ticker is TSRO and the CUSIP is 881569107. A total of 227 filers reported holding TESARO INC in Q4 2018. The put-call ratio across all filers is 0.46 and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $1,479,000 | +58.7% | 19,922 | -16.7% | 0.01% | +66.7% |
Q3 2018 | $932,000 | -12.5% | 23,903 | -0.2% | 0.01% | -14.3% |
Q2 2018 | $1,065,000 | -28.9% | 23,956 | -8.6% | 0.01% | -30.0% |
Q1 2018 | $1,497,000 | -40.4% | 26,201 | -13.6% | 0.01% | -41.2% |
Q4 2017 | $2,513,000 | -38.0% | 30,324 | -3.5% | 0.02% | -54.1% |
Q3 2017 | $4,056,000 | +2.2% | 31,420 | +10.8% | 0.04% | -7.5% |
Q2 2017 | $3,967,000 | -21.0% | 28,366 | -13.1% | 0.04% | -24.5% |
Q1 2017 | $5,023,000 | -4.7% | 32,642 | -16.8% | 0.05% | -8.6% |
Q4 2016 | $5,273,000 | +45.4% | 39,214 | +8.4% | 0.06% | +13.7% |
Q3 2016 | $3,627,000 | +16.2% | 36,183 | -2.6% | 0.05% | +27.5% |
Q2 2016 | $3,121,000 | +117.0% | 37,131 | +13.7% | 0.04% | +100.0% |
Q1 2016 | $1,438,000 | -22.9% | 32,667 | -8.3% | 0.02% | -13.0% |
Q4 2015 | $1,864,000 | +771.0% | 35,626 | +856.7% | 0.02% | +666.7% |
Q1 2015 | $214,000 | +3.9% | 3,724 | -51.4% | 0.00% | 0.0% |
Q3 2014 | $206,000 | -29.5% | 7,655 | -18.5% | 0.00% | -25.0% |
Q2 2014 | $292,000 | -33.8% | 9,394 | -37.2% | 0.00% | -33.3% |
Q1 2014 | $441,000 | +34.9% | 14,948 | +76.9% | 0.01% | -25.0% |
Q3 2013 | $327,000 | – | 8,452 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INTERWEST VENTURE MANAGEMENT CO | 2,021,403 | $271,838,000 | 64.82% |
NEA Management Company, LLC | 10,275,113 | $1,381,797,000 | 54.94% |
ORACLE INVESTMENT MANAGEMENT INC | 1,248,086 | $167,843,000 | 27.84% |
BLUE JAY CAPITAL MANAGEMENT, LLC | 89,695 | $12,062,000 | 7.28% |
Perceptive Advisors | 687,993 | $92,521,000 | 6.58% |
Avoro Capital Advisors LLC | 231,700 | $31,159,000 | 6.30% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 94,500 | $12,705,000 | 5.72% |
Rock Springs Capital Management LP | 613,500 | $82,503,000 | 5.52% |
SENZAR ASSET MANAGEMENT, LLC | 142,300 | $19,136,000 | 5.08% |
BB BIOTECH AG | 974,582 | $131,062,000 | 4.85% |